Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Clinical trial NCT04383743 · COMPLETED

Trial details

NCT number: NCT04383743
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8 Muscle Invasive Bladder Carcinoma

Start date: 2020-11-24
Primary completion: 2024-06-17
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.